Charles Schwab’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $448K | Sell |
29,959
-4,010
| -12% | -$59.9K | ﹤0.01% | 3174 |
|
|
2025
Q1 | $398K | Buy |
33,969
+3,652
| +12% | +$42.8K | ﹤0.01% | 3142 |
|
|
2024
Q4 | $693K | Hold |
30,317
| – | – | ﹤0.01% | 3039 |
|
|
2024
Q3 | $1.27M | Buy |
30,317
+741
| +3% | +$31.1K | ﹤0.01% | 2845 |
|
|
2024
Q2 | $1.08M | Buy |
29,576
+24,337
| +465% | +$886K | ﹤0.01% | 2911 |
|
|
2024
Q1 | $267K | Buy |
+5,239
| New | +$267K | ﹤0.01% | 3197 |
|
|
2022
Q2 | – | Sell |
-4,430
| Closed | -$167K | – | 3609 |
|
|
2022
Q1 | $167K | Hold |
4,430
| – | – | ﹤0.01% | 3332 |
|
|
2021
Q4 | $428K | Hold |
4,430
| – | – | ﹤0.01% | 3192 |
|
|
2021
Q3 | $641K | Hold |
4,430
| – | – | ﹤0.01% | 3056 |
|
|
2021
Q2 | $818K | Buy |
4,430
+302
| +7% | +$55.8K | ﹤0.01% | 2996 |
|
|
2021
Q1 | $1.02M | Buy |
4,128
+292
| +8% | +$71.9K | ﹤0.01% | 2855 |
|
|
2020
Q4 | $1.08M | Sell |
3,836
-7
| -0.2% | -$1.97K | ﹤0.01% | 2748 |
|
|
2020
Q3 | $923K | Buy |
3,843
+145
| +4% | +$34.8K | ﹤0.01% | 2692 |
|
|
2020
Q2 | $1.23M | Buy |
3,698
+2,995
| +426% | +$995K | ﹤0.01% | 2565 |
|
|
2020
Q1 | $160K | Hold |
703
| – | – | ﹤0.01% | 3048 |
|
|
2019
Q4 | $174K | Buy |
+703
| New | +$174K | ﹤0.01% | 3055 |
|
|
2019
Q3 | – | Sell |
-841
| Closed | -$40K | – | 3187 |
|
|
2019
Q2 | $40K | Hold |
841
| – | – | ﹤0.01% | 3163 |
|
|
2019
Q1 | $46K | Buy |
+841
| New | +$46K | ﹤0.01% | 3147 |
|